Pulmonx Corporation (LUNG) Reports In-Line Q1 EPS; Offers FY23 Revenue Guidance

Go back to Pulmonx Corporation (LUNG) Reports In-Line Q1 EPS; Offers FY23 Revenue Guidance
(NASDAQ: LUNG) Delayed: 2.42 +0.26 (12.04%)
Previous Close $2.16    52 Week High
Open $2.19    52 Week Low
Day High $2.49    P/E N/A 
Day Low $2.16    EPS
Volume 866,805